doi: 10.3389/fendo.2025.1669478 Received 19 July 2025 Accepted 02 October 2025 Published 27 October 2025 Volume 16 - 2025 Edited by Hongxue Shi, Louisiana State University Health Science Center Shreveport, United States Reviewed by Yang Xie, Flagship Pioneering, United States Eui Jung Jung, Columbia University Medical Center, United States Updates Copyright 2025 Mohiuddin, Neha, Mahir, Shakib, Alam, Wahiduzzaman, Barua, Shimu, Rahman, Hossain, Shariare, Mohib and Uddin
No contraindications: This includes a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), history of pancreatitis, severe gastrointestinal disease, or known hypersensitivity to tirzepatide
Results will of course vary based on length of your program and your weight loss needs
, , (), ,
Brands that appear in a health setting develop credibility with patients, because the products are psychologically received to have the same quality and authority they receive from care providers. She advises a careful and deliberate integration that would align brands with patients at every step from initial visits to weight loss centres, right through to follow-up appointments post GLP-use
Bottom line Mounjaro is a type 2 diabetes drug with the active ingredient, tirzepatide
